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Thuricin CD is a two-component bacteriocin, consisting of the peptides Trnα and Trnβ,
and belongs to the newly designated sactibiotic subclass of bacteriocins. While it is
clear from studies conducted thus far that it is a narrow-spectrum bacteriocin, requiring
the synergistic activity of the two peptides, the precise mechanism of action of thuricin
CD has not been elucidated. This study used a combination of flow cytometry and
traditional culture-dependent assays to ascertain the effects of the thuricin CD peptides
on the morphology, physiology and viability of sensitive Bacillus firmus DPC6349 cells.
We show that both Trnα and Trnβ are membrane-acting and cause a collapse of the
membrane potential, which could not be reversed even under membrane-repolarizing
conditions. Furthermore, the depolarizing action of thuricin CD is accompanied by
reductions in cell size and granularity, producing a pattern of physiological alterations
in DPC6349 cells similar to those triggered by the pore-forming single-component
bacteriocin Nisin A, and two-component lacticin 3147. Taken together, these results
lead us to postulate that the lytic activity of thuricin CD involves the insertion of thuricin
CD peptides into the membrane of target cells leading to permeabilization due to pore
formation and consequent flux of ions across the membrane, resulting in membrane
depolarization and eventual cell death.
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INTRODUCTION
Bacteriocins are ribosomally synthesized peptides that exert antimicrobial effects predominantly
against closely related bacteria, often in the nanomolar range (Cotter et al., 2013). Bacteriocins
are broadly classified into class I (post-translationally modified) and class II (unmodified)
bacteriocins. The mode of action of the most commonly studied subclass of bacteriocins,
the lantibiotics, involves the peptide(s) binding to lipid II, followed by pore formation in
some cases. Examples of such lantibiotics include Nisin A and lacticin 3147 (Wiedemann
et al., 2006; Field et al., 2010). In contrast, the mode of action of several class II
bacteriocins involves the mannose-phosphotransferase system as a receptor (Oppegård et al.,
2007). The mechanism of action of Gram negative bacteriocins such as microcins often
Abbreviations: BD, Becton Dickinson; BHI, brain heart infusion; CDI, Clostridium difficile infection; cFDA,
carboxyfluorescein diacetate; cfu, colony forming units; DiBAC4(3), Bis-(1,3-Dibutylbarbituric acid) Trimethine Oxonol;
DiOC2(3), 3,3′-diethyloxacarbocyanine iodide; DMSO, dimethyl sulfoxide; DPC, dairy products culture collection; FC,
flow cytometry; IPA, isopropanol; LB, Luria Bertani; MIC, minimum inhibitory concentration; OD, optical density; PBS,
phosphate buffered saline; PI, propidium iodide; RP-HPLC, reverse-phase high performance liquid chromatography; TFA,
tri-fluoroacetic acid.
Frontiers in Microbiology | www.frontiersin.org 1 April 2017 | Volume 8 | Article 696
fmicb-08-00696 April 17, 2017 Time: 12:23 # 2
Mathur et al. Thuricin CD Mechanism of Action
involves targeting DNA gyrase, RNA polymerase or Asp-tRNA
synthetase (Cotter et al., 2013). Recently, the mode of action of
the class II bacteriocin, lactococcin G, has been identified and
shown to involve the UppP protein as a receptor (Kjos et al.,
2014). In another recent study, sequencing of mutants displaying
attenuated sensitivity to plantaricin JK revealed a putative amino
acid transporter as a possible receptor for this class II bacteriocin
(Oppegård et al., 2016).
The sactibiotics are a relatively newly designated subgroup of
bacteriocins and include subtilosin A, thurincin H, propionicin
F, and thuricin CD (Arnison et al., 2013). With the exception
of subtilosin A, the sactibiotics described thus far are narrow
spectrum antimicrobials. Significantly, the peptides are relatively
hydrophobic in nature and their 3D structures tend to be hairpin-
shaped. The hydrophobic residues generally point outward,
indicating that these residues most likely interact with the
hydrophobic membrane of target strains. With respect to
elucidating the mode of action, there have been relatively few
studies conducted with the sactibiotic subclass of bacteriocins
thus far. The most comprehensive study of this nature involved
the sactibiotic subtilosin A by Thennarasu et al. (2005) in which
the authors described the interaction of the hydrophobic residues
of the peptide with the hydrophobic lipid bilayers of the target
membrane. Thuricin CD is one such example of a narrow-
spectrum sactibiotic bacteriocin and is composed of two peptides,
the 2763Da Trnα and 2861Da Trnβ, predominantly targeting
spore-forming Gram positive bacteria including all Clostridium
difficile strains tested (Rea et al., 2010). Both Trnα and Trnβ
also exhibit a characteristic sactibiotic hairpin-like structure
generated by three sulfur-to-α-carbon linkages and are relatively
hydrophobic, similar to other sactibiotics described (Sit et al.,
2011; Arnison et al., 2013). An unusual feature of thuricin CD
is that Trnα and Trnβ are similar in sequence and structure,
with 45.3% sequence similarity and 39.6% identity. This relatively
high percentage sequence and structural similarity suggests that
they may share a common receptor/binding site and may have
a similar function. However, it is clear that their actions are
synergistic (Rea et al., 2010). This high level of similarity is in
contrast to other two-component bacteriocins such as lacticin
3147, in which case the associated peptides, Ltnα and Ltnβ, share
no homology and are completely different in structure to each
other. These differences reflect different functions in that Ltnα
binds to lipid II and Ltnβ causes pore formation (Wiedemann
et al., 2006). Previous investigations had indicated that thuricin
CD may be a slow-acting bacteriocin relative to lacticin 3147. This
was determined by quantifying the release of the intracellular
enzyme acetate kinase from thuricin CD-sensitive C. difficile
cells subsequent to exposure to the bacteriocin, and the results
demonstrated that the rate of release of this enzyme was relatively
slow compared to lacticin 3147-treated cells. This comparatively
slow action, along with its narrow-spectrum nature, indicated
that the mode of action of thuricin CD is likely to differ from
that of the broad-spectrum lantibiotic, lacticin 3147 (Rea et al.,
2010).
The traditional culture-dependent analysis of cell viability
following antimicrobial challenge can be complemented by
flow cytometry (FC) in order to evaluate alterations in cell
morphology and physiology and to gain deeper insights into
the antimicrobial action of bacteriocins. Supported by an
ever increasing catalog of fluorescent probes enabling multi-
parametric assessment of bacterial physiology, FC allows us
to assess the impact of antimicrobials on the bacterial host
in real-time at both population and single-cell level. Studies
using FC to investigate the impact of bacteriocins on the
cells have generally utilized a combination of probes enabling
the assessment of changes in membrane integrity (e.g., Syto
9 and PI), membrane potential [e.g., DiBAC4(3), DiOC2(3)]
and intracellular metabolic activity (e.g., cFDA) (Ratinaud and
Revidon, 1996; Ueckert et al., 1997, 1998; Swarts et al., 1998;
Martínez et al., 2000; Shapiro, 2000; Budde and Rasch, 2001;
Dalmau et al., 2002; Weeks et al., 2006; Gou et al., 2010; Ayari
et al., 2012; Pal and Srivastava, 2014; Chopra et al., 2015). The
ability to study individual cellular events and to distinguish them
from the overall population response makes FC one of the most
appropriate tools to provide real-time information regarding the
potentially heterogeneous response of a bacterial population to a
bacteriocin.
In this study, we attempted to elucidate the mode of
action of thuricin CD by using FC to detect structural and
physiological changes in sensitive Bacillus firmus DPC6349 cells
upon exposure to individual, combined or sequentially added
Trnα and Trnβ. We hypothesized that the cell membrane is
a likely target for thuricin CD peptides, and thus we used
real-time FC to monitor the time course modifications in
size, complexity and membrane potential of sensitive cells. In
addition, we compared the time point viability data obtained
by FC analysis of membrane integrity with those generated
by traditional growth-based assays. Notably, we found that the
thuricin CD peptides elicit depolarization of the membrane,
most likely as a consequence of the pore-forming ability
of the peptides triggering the movement of ions across the
membrane, and this occurs with reductions in cell size and
granularity.
MATERIALS AND METHODS
Thuricin CD Purification
Thuricin CD for these assays was purified as described previously,
with minor alterations (Rea et al., 2010). Briefly, BHI broth
was initially clarified by passing through XAD-16 beads (Sigma
Aldrich) prior to autoclaving. Ten ml cultures of B. thuringiensis
DPC6431 (thuricin CD-producing strain) were grown in BHI
broth at 37◦C with vigorous agitation and the strain subcultured
two times in BHI broth prior to inoculating 1.5 L of clarified
BHI broth. The 1.5 L culture was grown overnight for 16 h
at 37◦C with agitation. The overnight culture was centrifuged
at 8260 g for 15 min and both the supernatant and cell pellet
were retained for further use. The cell pellet was resuspended
in 275 ml of 70% IPA, 0.1% TFA and stirred for 4.5 h at 4◦C.
The supernatant was passed through fresh XAD-16 beads in a
column and then washed with 500 ml of 40% ethanol. Thuricin
CD was eluted in 400 ml of 70% IPA, 0.1% TFA and this elute
was called S1. The cell pellet which was resuspended in 70%
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IPA, 0.1% TFA was centrifuged at 8260 g for 15 min and the
supernatant (S2) was added to S1. The IPA was subsequently
removed by subjecting the S1–S2 mix to rotary evaporation
(Buchi) and the sample was passed through a Phenomenex C-
18 column which had been pre-equilibrated with methanol and
water just before use. The column was washed with 120 ml
of 40% ethanol and thuricin CD eluted in 60 ml of 70% IPA,
0.1% TFA. This was further concentrated by removing the IPA
using rotary evaporation, before separating and purifying the
two peptides using RP-HPLC. Nisin A and lacticin 3147 were
purified as already described (Field et al., 2010; Draper et al.,
2013).
Minimum Inhibitory Concentration (MIC)
Assays
In this study, B. firmus DPC6349 was utilized as a surrogate
thuricin CD-sensitive host, in lieu of thuricin CD-sensitive
C. difficile strains. The aerobic growth conditions of DPC6349, in
conjunction with its class I status, facilitated the FC experiments
in this study. MIC assays were conducted as previously described
with minor modifications (Mathur et al., 2013). Briefly, cells of
the bacteriocin-sensitive strain B. firmus DPC6349 were grown
overnight for 16 h in LB broth at 37◦C with vigorous agitation
(150 rpm). The following day, the cells were subcultured until
they reached mid-logarithmic phase (an OD600 of approximately
0.5). At this point, cells were diluted such that the final inoculum
for MIC assays was approximately 5 × 105 cfu/ml. Thuricin CD
peptides, Nisin A and lacticin 3147 peptides were resuspended
in LB broth. The potassium ionophore, valinomycin, was initially
reconstituted in DMSO (Molecular Probes) prior to diluting in
PBS and subsequently diluting in LB broth. All antimicrobials
were finally diluted in LB broth to give the desired starting
concentrations and two-fold serial dilutions were performed
in 96-well microtitre plates, for MIC assays. MIC readings
were taken at 18 h and the MIC was defined as the lowest
concentration of the antimicrobial at which there was no
visible growth of the target strain. Assays were conducted in
triplicate.
Time Course FC Analyses of Membrane
Potential and Morphology in the
Bacterial Host during Bacteriocin
Challenge
Used alone or in combination with fluorescent probes, FC
enables the assessment of various structural and functional
cell properties, often leading to a deeper characterization of
the physiological heterogeneity of a microbial population (Díaz
et al., 2010). Membrane potential in microbial cells can be
detected by FC following staining with fluorescent lipophilic
cell-permeant probes such as DiOC2(3). This carbocyanine dye
exhibits red fluorescence in bacterial cells maintaining a large
membrane potential and a fluorescence shift toward green
emission as a result of membrane depolarization (Novo et al.,
1999). Conversely, fluorescence-independent monitoring by FC
of the forward (FSC) and side-angle (SSC) light scattering
properties of a bacterial population provides useful information
about morphological parameters such as cell size and internal
granularity/complexity, respectively (Díaz et al., 2010; Shapiro,
2015). The impact of the thuricin CD peptides, Trnα and
Trnβ, on the membrane potential and morphology of sensitive
B. firmus DPC6349 cells was therefore assessed by FC as
follows. Cells from a 100 µl aliquot of an overnight culture
were recovered by centrifugation (8260 g for 10 min), diluted
10-fold in 1 ml of LB broth and activated by incubation
at 37◦C for 30 min. At this point, the cells were diluted
a further 25-fold and stained for 30 min with a solution
of 6.3 µM DiOC2 (3) (Thermo Fisher Scientific), prepared
in PBS and containing 0.21% glucose to energize the cells
and thereby generate a large membrane potential. Aliquots of
1.4 ml of stained samples were acquired at medium flow rate
(35 µl/sec) using a BD Accuri C6 flow cytometer (Becton
Dickinson, Belgium) and a threshold of 10000 on FSC to
minimize background. Acquisition and analysis of DiOC2(3)
fluorescence (FL3, > 670 nm long pass), cell size (FSC) and
cell complexity/granularity (SSC) were carried out using the BD
Accuri C6 software v. 1.0.2 (Becton Dickinson, Belgium). The
microbial population was identified based on its light scattering
properties on FSC versus SSC bi-plots and a gating strategy
was used to discriminate it from background particles and
cell debris. The time course changes in membrane potential
and morphology of DPC6349 cells following challenge with
an antimicrobial were assessed using the “Run Unlimited”
function of the C6 flow cytometer. Unchallenged DiOC2(3)-
stained cells were initially acquired for 2 min to establish baseline
levels of membrane potential and morphological parameters.
Subsequently, a small aliquot of a 10–15x stock solution of an
antimicrobial in PBS was added and its effect on the physiology
of the sensitive target monitored over 15–25 min. The impact
on the host’s membrane potential of individual, combined and
sequentially added thuricin CD peptides, Trnα or Trnβ, was
compared to those exerted by the proton motive force (PMF)-
depleting agents Nisin A (Bruno et al., 1992), lacticin 3147
(McAuliffe et al., 1998), and valinomycin (Shapiro, 2004). Stock
solutions of valinomycin were prepared in DMSO, whereas
diluted working solutions were made using PBS. To generate
high external potassium conditions and trigger the membrane
depolarizing activity of valinomycin (Shapiro, 2004; Cronin,
2015), 150mM KCl was added to the PBS used to prepare
the DiOC2(3) staining solution. Assays were conducted in
duplicate.
Light Microscopy to Assess the Impact
of Thuricin CD on DPC6349 Cells
Overnight cultures of B. firmus DPC6349 cells were diluted
100-fold to yield a starting concentration of approximately 107
cfu/ml for light microscopy analysis. Cells were treated with
either 1 µM thuricin CD, 18 µM Trnα, 18 µM Trnβ or PBS
without any peptide (negative control) in a final volume of
1 ml. Fifty microliter aliquots were taken at time points 1, 3,
and 5 h for microscopy. A light microscope (Zeiss, Axioskop)
was utilized to evaluate the effects of the thuricin CD peptides
on the morphology and size of DPC6349 cells. Cells were
Frontiers in Microbiology | www.frontiersin.org 3 April 2017 | Volume 8 | Article 696
fmicb-08-00696 April 17, 2017 Time: 12:23 # 4
Mathur et al. Thuricin CD Mechanism of Action
magnified 1000× and images captured with Zeiss AxioCam
ERc5s.
Assessment of Bacterial Survival to
Bacteriocin Challenge by FC Analysis of
Membrane Integrity and Conventional
Plate Count Method
Overnight cultures of DPC6349 were diluted to a final
concentration of approximately 107 cfu/ml as described for the
membrane potential experiments above, with the exception that
LB broth was replaced by PBS as the dilution buffer. To assess the
effects of individual and combined thuricin CD peptides, diluted
DPC6349 cells were exposed to known equimolar concentrations
of Trnα, Trnβ or both peptides and incubated at 37◦C with
vigorous agitation (400rpm). To analyze the impact of the
sequential addition of the thuricin CD peptides, diluted DPC6349
cells were initially exposed to sub-lethal concentrations (1 µM)
of either Trnα or Trnβ for 1 h at 37◦C to allow the peptide to
adsorb to the cell surface. After this time, cells were recovered
by centrifugation (8260 g for 10 min), washed with PBS to
remove any unbound peptide and resuspended in a PBS solution
containing a lethal concentration (12 µM) of the second peptide.
Negative controls consisted of cells incubated in the absence
of any peptide and challenged and unchallenged cells were
sampled (100 µl) at various time points (0, 3, 5, and 21 h)
and serially diluted in PBS. FC analysis of membrane integrity
was carried out by staining appropriate dilutions (i.e., providing
less than 1000 cellular events per min to avoid coincidence
at the flow cytometer) of each sample with 6.68 µM Syto 9
and 40 µM PI from the Live/Dead R© BacLightTM viability kit
(Molecular Probes, USA) for 15 min at 37◦C, under agitation
(400 rpm) in the dark. While Syto 9 enters all cells regardless
of their membrane integrity status, PI usually only enters cells
with a permeabilized or compromised membrane and, due to
its higher binding affinity for nucleic acids, displaces Syto 9.
Consequently, live cells with an intact membrane generally
exhibit green fluorescence as they only contain Syto 9 whereas
dead cells with a compromised membrane are stained red by
PI. Injured cells with a permeabilized membrane will contain
both dyes in a ratio proportional to the degree of membrane
damage and will exhibit orange fluorescence (Shapiro, 2004,
2015). Stained samples were analyzed for 1 min at medium
flow rate (35 µl/sec) using a BD Accuri C6 flow cytometer
(Becton Dickinson, Belgium) and a threshold of 10000 on FSC to
minimize background. Acquisition and analysis of Syto 9 (FL1)
and PI fluorescence (FL3, > 670 nm long pass) were carried out
using the BD Accuri C6 software v. 1.0.2 (Becton Dickinson,
Belgium). The microbial population was identified based on its
light scattering properties on FSC versus SSC bi-plots and a
gating strategy was used to discriminate it from background
particles and cell debris. Assays were conducted in duplicate. For
viable plate counts, samples were prepared as described above
with serial dilutions conducted using PBS and dilutions plated on
LB agar to determine cfu/ml. At least three independent replicates
were used and significant differences assessed using Student’s
t-test for viable plate counts.
RESULTS
Assessment of the Minimum Inhibitory
Concentrations (MIC) of Various
Antimicrobials against Bacillus firmus
DPC6349
The MIC of thuricin CD against DPC6349 was found to be
approximately 24-fold lower than the MICs of the individual
peptides Trnα or Trnβ present on their own. In terms of molar
values, the MIC of lacticin 3147 was found to be four-fold lower
than that of thuricin CD, whereas the MIC of Nisin A was
approximately 2.5-fold higher than thuricin CD. Finally, the MIC
of the PMF-altering reagent valinomycin was five-fold higher
than thuricin CD and the MIC of the antibiotic chloramphenicol
was 60-fold higher than thuricin CD, again when expressed in
molar values (Table 1).
DiOC2(3) Enables Detection of
Membrane Depolarization and
Repolarization in B. firmus DPC6349
Cells
Dissipation of membrane potential and overall PMF is an
essential component of the lytic action of various membrane-
active antimicrobial peptides (Bruno et al., 1992; Maftah et al.,
1993). As the magnitude of these membrane polarization
changes can vary between bacteria (Novo et al., 1999; Shapiro,
2004), the ability of the probe DiOC2(3) to detect depolarizing
and repolarizing alterations in the membrane potential of
DPC6349 cells was assessed using antimicrobials with known
mechanisms of action. Preliminary tests revealed a depolarized
membrane in 16 h-grown cells, probably as a result of the
limiting nutrient conditions typical of stationary phase cells.
Consequently, glucose was added to the DiOC2(3) staining
solutions in order to energize the cells and favor the restoration
of a resting basal membrane potential. Nisin A is known to
fully dissipate the membrane potential and pH gradient in
energized cells, leading to the complete collapse of the PMF
(Bruno et al., 1992), and was therefore used to test assay
functionality. FC analysis showed that DiOC2(3) red fluorescence
accumulated to approximately 5 logs arbitrary units in energized
DPC6349 cells (Figure 1A). Two minutes after the membrane
TABLE 1 | Minimum inhibitory concentrations of various antimicrobials
against B. firmus DPC6349.
Antimicrobial MIC µM/(µg/ml)
Thuricin CD 0.125 (0.704)
Trnα 3 (8.29)
Trnβ 3 (8.58)
Nisin A 0.312 (1.046)
Lacticin 3147 0.031 (0.191)
Chloramphenicol 7.5 (2.423)
Valinomycin 0.625 (0.69)
MIC values expressed in µg/ml are indicated in parentheses in bold.
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FIGURE 1 | Effects of Nisin A, lacticin 3147, chloramphenicol and valinomycin on the membrane potential, cell size and cell granularity of B. firmus
DPC6349: The probe DiOC2(3) was used to ascertain the effects of (A) 3 µM Nisin A, (B) 93 nM lacticin 3147, (C) 24 µM chloramphenicol, and (D) 156 nM
valinomycin. A reduction in DiOC2(3) fluorescence indicates membrane depolarization whereas decreases in FSC-H and SSC-H values indicate decreases in cell size
and cell granularity, respectively. The black arrow depicts the point at which the respective antimicrobials were added.
potential baseline was established, cells were exposed to 3 µM
(approximately 10x MIC) of Nisin A. A very fast membrane
depolarization occurred within 4 min of adding the peptide,
as revealed by a major reduction in red fluorescence emission
of DiOC2(3)-stained cells. Interestingly, the onset of membrane
depolarization was accompanied by decreases in cell size (FSC)
and granularity/complexity (SSC), probably as a consequence
of cell lysis (Figure 1A). Similar changes in cell physiology
were triggered by the application of 93 nM (approximately 3x
MIC) of lacticin 3147 (Figure 1B). Lacticin 3147 is a two-
peptide lantibiotic bacteriocin which has also previously been
shown to alter the membrane potential in sensitive Lactococcus
lactis subsp. cremoris HP cells (McAuliffe et al., 1998). In
contrast, no membrane depolarization and reduction in cell
size was elicited by the addition of 24 µM of chloramphenicol
(approximately 3x MIC) (Figure 1C). Chloramphenicol is known
to exert its antimicrobial action by inhibiting protein synthesis
without causing any alteration in the membrane potential
of target cells (Novo et al., 2000; Schifano et al., 2013).
Finally, the FC assay was tested using valinomycin, which is
a potassium ionophore able to depolarize or hyperpolarize the
bacterial membranes under conditions of either high or low
environmental potassium, respectively (Shapiro, 2004). In the
presence of high concentrations (150 mM) of extracellular KCl,
addition of 156 nM (0.25x MIC) valinomycin resulted in an
immediate and sharp membrane depolarization, probably caused
by a rapid influx of K+ ions into the cells (Figure 1D). Most
of the microbial population reacted to this forced depolarization
and was able to repolarize the membrane after a few minutes.
This was most likely mediated by the activation of an eﬄux
pump leading to the extrusion of the excess intracellular K+
ions which may have accumulated inside the cells. However,
a percentage of the population lost the ability to maintain a
constant ionic equilibrium at the two sides of the membrane and
remained in a depolarized state (Figure 1D). As expected at this
sublethal concentration (0.25x MIC), no reduction in cell size or
granularity accompanied the membrane depolarization triggered
by valinomycin (Figure 1D).
Thuricin CD Peptides Permeabilize and
Depolarize the Membrane of B. firmus
DPC6349
In an attempt to elucidate the mode of action of thuricin CD,
DiOC2(3) staining and real-time FC were used to monitor the
time course impact of equimolar concentrations of individual
and combined thuricin CD peptides on the membrane potential
of B. firmus DPC6349 (Figures 2A–C). When tested at the
MIC of individual peptides (3 µM), both individual peptides
triggered membrane depolarization accompanied by reductions
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FIGURE 2 | Effects of 3 µM thuricin CD peptides on the membrane potential, cell size and cell granularity of B. firmus DPC6349: The dye DiOC2(3)
was used to evaluate the effects of (A) 3 µM Trnα, (B) 3 µM Trnβ, and (C) 3 µM thuricin CD. The black arrow depicts the point at which the thuricin CD peptides
were added.
in cell size (FSC) and internal granularity (SSC) (Figures 2A,B).
These patterns of physiological changes in the sensitive host
were similar to those exerted by Nisin A (Figure 1A) and
lacticin 3147 (Figure 1B), thereby suggesting that the individual
thuricin CD peptides are able to permeabilize and depolarize the
membrane of target cells. The combined thuricin CD peptides
(Figure 2C) were also found to depolarize the membrane and
elicited similar decreases in cell size and cell granularity as
the individual peptides. In contrast to the lantibiotics Nisin A
and lacticin 3147 (Figures 1A,B) which triggered very sharp
changes in depolarization, the thuricin CD peptides appeared
to cause a more gradual depolarization (Figures 2A–C). The
thuricin CD peptides were also tested at concentrations three-fold
their MIC (9 µM) (Figures 3A–C) and at these concentrations,
it was found that the combined peptides (Figure 3C) caused
faster depolarization (approximately 5 min after addition of
the peptides) compared to the initiation of depolarization
approximately 10 min after addition of 9 µM Trnα (Figure 3A)
and approximately 7 mins after the addition of 9 µM Trnβ
(Figure 3B). A greater degree of depolarization was apparent at
these higher concentrations, compared to lower concentrations
of 3 µM (Figures 2A–C).
Membrane Depolarization Is an Integral
Part of the Lytic Action of Thuricin CD
Sequential challenge experiments were conducted to determine
whether valinomycin can interfere with the ability of thuricin
CD peptides to affect membrane potential (Figure 4). DPC6349
cells were stained with DiOC2(3) in the presence of 150 mM
environmental K+ ions to favor the depolarizing activity of
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FIGURE 3 | Effects of 9 µM thuricin CD peptides on the membrane potential, cell size and cell granularity of B. firmus DPC6349: The effects of (A)
9 µM Trnα, (B) 9 µM Trnβ, and (C) 9 µM thuricin CD were assessed by using the probe DiOC2(3). The black arrow depicts the point at which the thuricin CD
peptides were added.
valinomycin and analyzed by real-time FC. Two minutes after
the membrane potential baseline was established, addition
of 156 nM valinomycin triggered membrane depolarization-
repolarization events (Figure 4A) similar to those previously
described (Figure 1D). Once the cells had restored their resting
membrane potential, 18 µM thuricin CD was added and its
effects monitored over time (Figure 4A). Within approximately
5 min, the sactibiotic caused full membrane depolarization and
this effect could not be reversed even after further addition
of 156 nM valinomycin (Figure 4B). Despite the presence of
valinomycin and conditions favoring membrane repolarization
due to potential cellular uptake of K+, thuricin CD’s impact
on the DPC6349 membrane was such that cells were unable
to counteract the depolarizing action of the sactibiotic. Again,
decreases in cell size (FSC) and granularity (SSC) were observed
in parallel with the onset of membrane depolarization, further
suggesting this latter event as being an integral part of the lytic
activity of thuricin CD (Figures 4A,B). Similar experiments
conducted using each individual thuricin CD peptide showed
that both Trnα and Trnβ were also able to force membrane
depolarization in DPC6349 cells despite the repolarizing capacity
of valinomycin (Figures 4C,D). However, the time course
depolarization caused by the individual peptides was slightly
slower with 18 µM Trnα causing depolarization approximately
9 min after the addition of the peptide, while 18 µM Trnβ
elicited depolarization approximately 7 min after the addition
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FIGURE 4 | Effects of the potassium ionophore valinomycin, alone and in combination with thuricin CD peptides: (A) 156 nM valinomycin (0.25x MIC;
black arrow) followed by 18 µM thuricin CD (dark gray arrow) to ascertain its effects on the membrane potential of DPC6349; (B) 156 nM valinomycin (0.25x MIC;
black arrow) followed by 18 µM thuricin CD (dark gray arrow), followed by a second addition of 156 nM valinomycin (light gray arrow); (C) 156 nM valinomycin (0.25x
MIC; black arrow) followed by 18 µM Trnα (dark gray arrow); and (D) 156 nM valinomycin (0.25x MIC; black arrow) followed by 18 µM Trnβ (dark gray arrow).
of the peptide. This slower depolarizing effect compared to the
combined peptides is in agreement with initial observations
(Figures 3A–C).
Light microscopy was also conducted in order to assess
the impact of the thuricin CD peptides on DPC6349 cells
(Figure 5). Compound microscope image analysis revealed that
the membranes of the cells began to degrade upon exposure to
the thuricin CD peptides, either individually or in combination,
and this was in contrast to the negative control (PBS only)
which remained relatively intact (Figure 5). The thuricin CD
peptides resulted in the appearance of less dense regions in the
membrane (red arrows) likely indicating that the membrane was
being damaged due to the thuricin CD peptides. Exposure to the
peptides also resulted in the emergence of smaller fragmented
cells (red circles), perhaps indicative of cell lysis (Figure 5).
Sequential Addition of Thuricin CD
Peptides and Effects on the Membrane
Potential of B. firmus DPC6349
The antimicrobial activity of two-peptide bacteriocins is
often linked to distinct roles and sequential action of
both components (Wiedemann et al., 2006; Oppegård
et al., 2007; Cotter et al., 2013). To test whether such a
specific sequential action is also required for the activity of
thuricin CD, DPC6349 cells were exposed to either Trnα
(black arrow) or Trnβ (gray arrow) for 4 min before being
challenged by equimolar concentrations of the second peptide
(Figures 6A–D). At concentrations of 3 µM (1x MIC of
the individual peptides), there was little or no difference
between the addition of Trnα followed by addition of
Trnβ, compared to the addition of Trnβ prior to Trnα
(Figures 6A,B). Both treatments triggered depolarization
and decreases in cell size and granularity approximately
13 min after the addition of the first peptide. However,
when used at 3x MIC (9 µM), marginally quicker membrane
depolarization and reductions in cell size and granularity
were triggered by Trnβ-Trnα sequential addition (initiation
of depolarization occurred approximately 6 min after the
addition of the first peptide) compared to the opposite order
(initiation of depolarization occurred approximately 8 min
after the addition of the first peptide) (Figures 6C,D).
These results are in stark contrast to those previously
observed with lacticin 3147, where sequential addition
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FIGURE 5 | Compound microscope image analysis of B. firmus DPC6349 cells upon exposure to thuricin CD peptides: (A) DPC6349 cells in PBS;
(B) DPC6349 cells exposed to 1 µM thuricin CD; (C) DPC6349 cells treated with 18 µM Trnα; (D) DPC6349 cells treated with 18 µM Trnβ. Time points 1, 3, and 5 h
post-exposure are shown. The red arrows depict regions of the membrane which have become less dense due to the peptides. Smaller, fragmented cells are
depicted by the red circles.
had a major effect on activity (Morgan et al., 2005),
unlike the minor differences seen here with thuricin CD
peptides.
Effects of 12 µM Thuricin CD
Concentrations on the Membrane
Integrity of B. firmus DPC6349
The effects of a lethal concentration (12 µM) of individual
and combined thuricin CD peptides on the viability of
DPC6349 cells were assessed by using end-point FC after
staining with the membrane integrity probes Syto 9 and PI
(Figure 7A). FC quantification of live cell counts, as determined
by the number of cells excluding PI, revealed that 12 µM
Trnα was more effective at causing lethal membrane damage
than 12 µM Trnβ, as a greater decrease in cell counts
was apparent after time points 3 and 5 h (Figure 7A). As
expected, 12 µM thuricin CD caused greater decreases in
cell counts over time, compared to equimolar concentrations
of the individual peptides. The pre-incubation of cells with
1 µM Trnα prior to adding 12 µM Trnβ appeared to
elicit a more pronounced killing effect, compared to cells
pre-incubated with 1 µM Trnβ prior to the addition of 12 µM
Trnα.
Viable plate counts in terms of cfu/ml confirmed the
trends highlighted by FC analyses (Figure 7B). When used
independently, Trnα caused significant reductions in viable cell
counts after 3, 5, and 21 h (all P < 0.001), compared to counts
at T0. In contrast, Trnβ used independently merely caused
significant reductions in viable counts after 3 h (P < 0.05)
and 5 h (P < 0.001) but failed to cause a decrease in
viable counts after 21 h, compared to values at T0. The most
drastic reduction in viable cell counts was obtained for 12 µM
thuricin CD, with the failure to recover any colonies at time
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FIGURE 6 | Effects of sequential addition of equimolar concentrations of the thuricin CD peptides: The fluorochrome DiOC2(3) was utilized to
evaluate the impact of (A) adding 3 µM Trnα followed by 3 µM Trnβ; (B) 3 µM Trnβ followed by 3 µM Trnα; (C) 9 µM Trnα followed by 9 µM Trnβ; and (D) 9 µM
Trnβ followed by 9 µM Trnα, on membrane potential, cell size and cell granularity. The black arrow depicts the addition of Trnα and the gray arrow represents the
point of addition of Trnβ in every instance.
points 3, 5, and 21 h (all P < 0.05). Similarly, the pre-
incubation of cells with 1 µM Trnα prior to adding 12 µM
Trnβ caused significant reductions in viable counts after 3,
5, and 21 h (all P < 0.001). Finally, significant decreases in
viable counts were also obtained for samples pre-incubated with
1 µM Trnβ prior to adding 12 µM Trnα (all P < 0.01). As
was the case for the membrane potential findings described
above, the sequential addition of the thuricin CD peptides
did not appear to be an important factor governing cell
viability.
DISCUSSION
In this study, real-time FC was utilized to monitor the time
course alterations in membrane potential and physiology of
sensitive B. firmus DPC6349 cells upon exposure to individual
and combined Trnα and Trnβ peptides. The results confirm that
the two peptides behave in a synergistic manner. Membrane
depolarization and damage to its integrity was found to
be expedited in target cells when Trnα and Trnβ acted
synergistically. This finding is consistent with the 24-fold
higher potency of thuricin CD, in terms of MIC value,
over that of either Trnα or Trnβ alone. This synergistic
activity is also shared by other two-component bacteriocins,
including lacticin 3147 (Wiedemann et al., 2006). As expected,
the rate of depolarization was found to be concentration-
dependent, with higher concentrations of either the individual
or combined peptides causing faster or greater degrees of
depolarization.
We also show that the onset of membrane depolarization
is concurrent with decreases in the FSC and SSC properties
of the target cells. As these latter markers represent a measure
of cell size (FSC) and granularity (SSC), this suggests that the
thuricin CD peptides can trigger membrane depolarization, cell
lysis and alterations of internal structure due to leakage of
intracellular components. Such a mechanism of action would
be typical of pore-forming bacteriocins such as Nisin A, which
is known to cause cell lysis upon binding to the peptidoglycan
precursor lipid II prior to forming pores in the membrane
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FIGURE 7 | Effects of 12 µM thuricin CD peptides on cell membrane integrity: (A) The probes Syto 9 and PI were used to evaluate effects on the membrane
integrity of DPC6349 cells by adding one of the following: 12 µM Trnα; 12 µM Trnβ; 12 µM thuricin CD; pre-incubation with 1 µM Trnα followed by the addition of
12 µM Trnβ; cells pre-incubated with 1 µM Trnβ followed by the addition of 12 µM Trnα; PBS on its own (negative control). Live cell counts as quantified by FC at
time points 0, 3, 5, and 21 h are shown. (B) Viable counts (cfu/ml) on LB agar plates showing recovery of DPC6349 cells exposed to the conditions described
above. Asterisks indicate statistically significant decreases in cfu/ml counts for each sample, relative to cfu/ml counts at T0 for each respective sample. ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001.
(Field et al., 2015). When tested, Nisin A caused depolarization
and decreases in size and granularity of DPC6349 cells, as
observed with the thuricin CD peptides. Since thuricin CD
is a narrow spectrum bacteriocin, it is likely that a receptor
other than lipid II is bound by the peptides, followed by
pore formation. Such a specific receptor may be present in
only a relatively small number of sensitive target species
such as C. difficile and B. firmus. The precise nature of this
interaction between the thuricin CD peptides and a putative
unique receptor could contribute to the differences in MICs
between thuricin CD and other bacteriocins such as Nisin A
and lacticin 3147 against the same target strain. Furthermore,
it may be the case that there are subtle differences in the
extent/precise rate of leakage of ions across the membrane and
consequent depolarization and cell death caused by different
bacteriocins, resulting in differences in the MIC against the same
target.
In contrast to the bacteriocins we investigated, the potassium
ionophore, valinomycin, did not elicit any decrease in cell
size and granularity despite causing very rapid membrane
depolarization. Furthermore, light microscopy analyses showed
the presence of shorter rods in DPC6349 cells after 1 h
of exposure to thuricin CD peptides, whereas small and
apparently fragmented cells, resembling remnants of lysed
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cells, were detected after 5 h of treatment. Altogether, these
results led us to hypothesize that the mode of action of
thuricin CD involves pore formation, eliciting membrane
depolarization due to the influx/eﬄux of ions across the
membrane and ultimately resulting in lysis of the target
cells.
To provide further support for this hypothesis, sequential
addition studies were carried out whereby DPC6349 cells
were initially exposed to valinomycin before being challenged
with either the individual peptides or combinations of the
thuricin CD peptides. Valinomycin alters only the membrane
potential component of the PMF by facilitating the movement
of K+ ions from areas of high to low concentration (Bruno
et al., 1992; Maftah et al., 1993; Lamsa et al., 2012). Under
conditions of high (150 mM) extracellular K+ ions, sub-
lethal concentrations (156 nM) of valinomycin triggered an
extremely swift and large depolarization in DPC6349 cells,
most likely due to a valinomycin-induced transfer of these K+
ions toward the negatively charged intracellular environment.
Within a few minutes, DPC6349 cells counteracted this
depolarization and rapidly restored their basal membrane
potential, presumably by activating ATPase eﬄux pumps to
extrude excess K+ ions. Addition of thuricin CD again caused
cell depolarization, which this time appeared to be irreversible,
even after further supplementation with valinomycin. This
suggests that thuricin CD causes a rapid loss of membrane
functionality and/or integrity in DPC6349 cells, which are thus
unable to restore the ionic equilibrium at both sides of the
membrane. This mechanism is generally associated with the
antimicrobial activity of pore-forming bacteriocins (Wiedemann
et al., 2006; Field et al., 2010, 2015; Noll et al., 2011).
A similar ability to cause permanent membrane depolarization
was also observed with Trnα and Trnβ alone, indicating
that each of the individual peptides may also be able to
form pores. Such permeabilization of the cell membrane and
reduction in membrane potential, due to transport of ions
across the membrane, has also been reported for the bacteriocin
mesentericin Y105 (Maftah et al., 1993). Interestingly, a separate
study involving another sactibiotic, subtilosin A, revealed that
a ‘buried orientation’ adopted by the subtilosin A peptide
upon interaction with the membrane triggers conformational
changes in the lipid bilayers causing membrane permeabilization
(Thennarasu et al., 2005). Due to the relatively hydrophobic
nature of the thuricin CD peptides, it is plausible that
the hydrophobic residues of Trnα and Trnβ also interact
with the lipid bilayers in membranes of target cells akin
to subtilosin A. An interaction of this nature between the
thuricin CD peptides and the hydrophobic membrane could
result in alterations of the shape of the membrane, facilitating
pore formation, consequent depolarization and eventual cell
death.
Kinetic FC analyses were also employed to ascertain the real-
time changes in membrane potential caused by the sequential
action of thuricin CD peptides in this study. By exposing the cells
to either one of the peptides for a short duration of time followed
by the addition of the second peptide, we ultimately aimed to
evaluate whether the antimicrobial activity of thuricin CD is
linked to the specific role and sequential action of its components,
as reported for other two-peptide bacteriocins (Wiedemann et al.,
2006; Oppegård et al., 2007; Cotter et al., 2013). At 3x MIC of the
individual peptides, a marginally faster effect on depolarization
and consequent decreases in cell size and granularity was
observed when Trnβ was added prior to Trnα, as compared to
the reverse order. However, Trnα appeared to cause a slightly
sharper decrease in cell size relative to the steadier reduction
elicited by Trnβ, suggesting that Trnβ could be more efficient at
eliciting depolarization of the membrane whereas Trnα may be
faster at triggering cell lysis. Nonetheless, the differences between
the sequential addition experiments were extremely small. Viable
counts obtained by both FC analysis of PI-negative cells and
traditional plating methods also confirmed that 12 µM Trnα had
a marginally faster killing effect than equimolar concentrations of
Trnβ. The pre-incubation of cells with sub-lethal concentrations
of one of the peptides followed by the addition of higher amounts
of the second peptide revealed that there was little difference
between the treatments in terms of the sequential addition of
the peptides, when assessed with membrane integrity probes.
Pre-incubation of cells with higher concentrations would likely
have resulted in cell lysis and cell death, precluding the precise
assessment of the effects of sequential addition of the peptides.
Unlike our membrane potential experiments which permitted
the sequential addition of the thuricin CD peptides in real-time,
our membrane integrity sequential addition assays were reliant
on the capacity of the individual peptides to adsorb to the cell
surface before being washed off with PBS to remove any unbound
peptide. A marked decrease in cfu/ml was found for cells which
were pre-incubated with sub-lethal concentrations of one of the
peptides followed by the addition of higher concentrations of the
second peptide. Notably, cells treated with 12 µM thuricin CD
failed to recover and form colonies on agar plates. The failure
of colonies to recover even upon transfer to rich media may
be due to the bactericidal effects and extensive cell lysis caused
by the synergistic interactions of the thuricin CD peptides. It
is plausible that Trnα and Trnβ target very similar or almost
identical receptors in the membrane. It may be the case that
binding of one of the thuricin CD peptides to the receptor
triggers a conformational change in the receptor and/or nearby
proteins or structures. A potential conformational alteration of
this nature may expose the binding site of another receptor,
facilitating recruitment of the other thuricin CD peptide. All
these effects may lead to faster and/or a greater degree of
pore formation when the two peptides potentiate each other’s
effects.
In conclusion, this is the first study conducted to gain initial
insights into the mechanism of action of the sactibiotic thuricin
CD. The similar structure of the two thuricin CD peptides,
their potent activity against Gram positive spore-formers and
the observations from this study which indicate that sequential
addition of the peptides has negligible effects, point to a
unique mechanism of action for these peptides. Furthermore, the
extremely narrow spectrum of activity and the lack of resistant
mutants (Rea et al., 2010) may indicate that the receptor for
thuricin CD could be an essential protein/structure that is present
in B. firmus and C. difficile and unique to certain spore-forming
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cells and absent in non-target species. Mutation/disruption of
such an essential receptor/protein in target cells likely precludes
the isolation of any resistant mutants. Due to the narrow-
spectrum activity of thuricin CD, it is highly unlikely that lipid
II is a target receptor for thuricin CD. Thus, while we have not
identified a specific receptor/binding site here or elucidated the
precise nature of the synergistic interactions of the peptides, this
study nonetheless reveals for the first time that both Trnα and
Trnβ have the ability to cause alterations of the membrane, and
that the onset of depolarization triggered by the pore-forming
ability of thuricin CD peptides is accompanied with decreases in
cell size and granularity, indicating cell lysis.
CONCLUSION AND PERSPECTIVES
Elucidating the mechanism of action of bacteriocins is a key
step in potentially utilizing them for therapeutic purposes.
Since thuricin CD is a narrow-spectrum bacteriocin with potent
activity mainly against C. difficile strains, it has great potential
for use as an alternative therapeutic option to treat C. difficile
infection (CDI), which is often caused by extensive damage
to the gut microbiota due to the use of broad-spectrum
antibiotics. Here, we used a thuricin CD-sensitive B. firmus
strain as an alternative host to study the effects of thuricin
CD on the physiology of sensitive bacterial cells. The data
presented here demonstrates that thuricin CD inflicts significant
damage on the cell membrane and that depolarization of the
membrane is likely to be a critical step in this process. By
employing the use of FC to gain insights into thuricin CD’s
impact on membrane potential and membrane integrity, in
conjunction with traditional cell viability assays, we conclude that
depolarization causes decreases in cell size and cell complexity
and this is likely to be due to the lytic action of the thuricin CD
peptides.
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